RSV Vaccine in Pregnancy: Protecting the Baby After Birth
Key message: Maternal RSV vaccination can pass antibodies through the placenta and reduce severe RSV illness in the…
Key message: Maternal RSV vaccination can pass antibodies through the placenta and reduce severe RSV illness in the baby during early life. The product, pregnancy window, season and alternative infant antibody programme differ between countries and must be verified locally.
Get urgent help: Call emergency services for breathing difficulty, facial or tongue swelling, collapse or severe hives after vaccination. Fever, significant illness, bleeding, contractions, fluid leakage or reduced baby movements needs maternity assessment rather than being assumed to be a vaccine effect.
What is RSV and why does it matter?
Respiratory syncytial virus is common and usually causes a cold in adults, but young infants can develop bronchiolitis, pneumonia, feeding difficulty or need hospital care.
Protection is particularly important in the first months when the baby’s own immune response is immature.
How does maternal vaccination protect the baby?
The mother produces antibodies after vaccination and transfers them across the placenta. Protection is therefore affected by gestation and the interval between vaccination and birth.
Maternal vaccination protects the infant; it is not a vaccine injected into the fetus.
When is it given?
Timing differs substantially between national programmes. Current UK guidance offers maternal RSV vaccination from around 28 weeks, while the US maternal programme uses a later 32–36-week seasonal window for the licensed maternal product.
A clinic in Egypt must not copy either schedule until the locally licensed product, national recommendation and seasonal programme are confirmed.
Is it seasonal or year-round?
Some programmes vaccinate throughout the year because the infant’s birth date determines the protection period; others use seasonal maternal vaccination according to RSV circulation.
Local epidemiology and programme design determine whether a dose is offered in a particular month.
What if the baby is born soon after vaccination?
There may be less time for antibody transfer when birth occurs shortly after vaccination. Some programmes use an infant long-acting monoclonal antibody instead of, or in selected circumstances after, maternal vaccination.
The baby should not routinely receive both strategies unless the current local programme identifies a reason.
Who may need individual specialist advice?
- Imminent preterm birth.
- Previous severe reaction to a vaccine component.
- Immune suppression or a complex medical condition.
- Uncertainty about whether a previous dose was maternal RSV vaccine.
- Twin or multiple pregnancy with an early planned birth.
- A baby expected to have a high-risk heart, lung or immune condition.
What side effects are expected?
- Pain, redness or swelling in the arm.
- Fatigue, headache or muscle aches.
- Mild fever or feeling unwell for a short time.
- Severe allergic reaction is rare.
What do safety monitoring and counselling include?
Regulators and maternity programmes continue to monitor pregnancy, preterm-birth and newborn outcomes. The benefit–risk discussion should use the currently licensed product information and national recommendation rather than claims about a different product or country.
A temporal event after vaccination does not by itself prove that the vaccine caused it.
Does the baby still need routine vaccines?
Yes. Maternal RSV vaccination is a specific early-life protection strategy and does not replace routine childhood immunisation.
Parents should still know newborn warning signs such as difficult breathing, grunting, poor feeding, unusual sleepiness or blue/grey colour.
Frequently asked questions
Is the RSV vaccine given to the baby before birth?
No. It is given to the mother so her antibodies cross the placenta.
Why does the recommended week differ between countries?
Programmes use different licensed products, epidemiology and implementation strategies.
Can it be given with flu or pertussis vaccine?
Some programmes allow coadministration of non-live vaccines, but follow the local product and programme guidance.
Does every baby need an antibody injection after maternal vaccination?
No. Most programmes select either maternal vaccine or infant antibody unless special circumstances apply.
Will it prevent every RSV infection?
No. It reduces the risk of severe disease but cannot prevent every infection.
Your next step
Before offering RSV vaccination, verify the exact maternal product licensed in Egypt, gestational window, season, clinic availability and the infant monoclonal-antibody policy.
Medical and content review: Dr Mohamed Abdelghany, Obstetrics & Gynecology Specialist, MRCOG (UK), MSc Obstetrics & Gynecology – Kasr Al-Ainy, Cairo University.
Last reviewed: 23 August 2026.
This information is for general education and does not replace individual medical assessment.
